The Official Website of the Long-Term Investor
Results 61 - 70 of 12671 : Previous 3 4 5 6 7 8 9 10 11 Next
Has Intuitive Surgical Become the Perfect Stock?
Finding companies that have all the right stuff can produce winners.
The Promise and Peril of the Mass-Market Genome
The $1,000 barrier is broken -- but are we ready?
A Year's Worth of Sales in 1 Month
Regeneron's Eylea hits the gates running.
Human Genome Sciences needs to accelerate growth.
4-Star Stocks Poised to Pop: SanDisk
Market-trouncing returns could be written in this 4-Star.
This Just In: Upgrades and Downgrades
Thumbs-up for EXACT Sciences and DepoMed, but Amylin isn't so lucky.
3 Earnings Beats That Caught My Attention Last Week
Wall Street ignored these earnings beats, but this Fool didn't.
3 Reasons Hep C Premiums Might Not Last
Careful what you wish for.
Don't Believe This Company's Warning
VIVUS' news is great news.
Inhibitex Is an Instant Double
Some takeout rumors do come true.
Results 61 - 70 of 12671 : Previous 3 4 5 6 7 8 9 10 11 Next
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK